Neo Ivy Capital Management - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2023$2220.0%3,516
-30.7%
0.12%
-22.0%
Q4 2022$222
-99.9%
5,070
+101.8%
0.15%
-65.6%
Q3 2022$166,000
+245.8%
2,512
+485.5%
0.44%
+722.6%
Q4 2020$48,000429
+14200.0%
0.05%
Q2 2020$030.0%0.00%
Q2 2019$030.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Boxer Capital, LLC 705,159$12,728,00012.46%
BVF INC/IL 2,640,251$47,657,00011.79%
Casdin Capital, LLC 321,300$5,799,0006.66%
Opaleye Management Inc. 220,000$3,971,0002.48%
PFM Health Sciences, LP 1,420,511$25,640,0000.79%
Perceptive Advisors 404,404$7,299,0000.64%
Partner Investment Management, L.P. 18,788$339,0000.55%
Visium Asset Management, LP 1,265,025$22,834,0000.39%
DRIEHAUS CAPITAL MANAGEMENT LLC 661,717$11,944,0000.39%
Virtus ETF Advisers LLC 10,484$189,0000.26%
View complete list of BLUEPRINT MEDICINES CORP shareholders